Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
BJC Reports|April 24, 2025
Monitoring circulating tumor DNA by recurrent hotspot mutations in bladder cancerShigehiro Tsukahara, Masaki Shiota, Takashi Matsumoto, et al.
Asian Journal of Endoscopic Surgery|January 11, 2024
Salvage robot-assisted radical prostatectomy after carbon ion radiotherapy to the prostateMasaki Shiota, Shigehiro Tsukahara, Dai Takamatsu, et al.
European Urology Open Science|July 3, 2025
Secular Trends in the Prevalence of Total and Latent Prostate Cancer over Half a Century According to Consecutive Autopsy Cases in a Japanese community: The Hisayama StudyJunichi Taira, Kenji Kawatoko, Dai Takamatsu, et al.
Human Pathology|March 20, 2022
Approach for reclassification of collecting duct carcinoma and comparative histopathological analysis with SMARCB1/INI1-deficient renal cell carcinoma and fumarate hydratase-deficient renal cell carcinomaDaisuke Kiyozawa, Kenichi Kohashi, Dai Takamatsu, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|December 8, 2022
Correlation between extended pelvic lymph node dissection and urinary incontinence at early phase after robot-assisted radical prostatectomyKen Lee, Masaki Shiota, Dai Takamatsu, et al.
Andrologia|November 8, 2021
Clinical impact of HSD3B1 polymorphism by metastatic volume and somatic HSD3B1 alterations in advanced prostate cancerMasaki Shiota, Naohiro Fujimoto, Yohei Sekino, et al.
Scientific Reports|July 21, 2021
Tumor microenvironment in giant cell tumor of bone: evaluation of PD-L1 expression and SIRPα infiltration after denosumab treatmentYu Toda, Kenichi Kohashi, Hidetaka Yamamoto, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|June 17, 2025
Risk Model for Lymph Node-Positive Prostate Cancer After Radical ProstatectomyKojiro Tashiro, Keiichiro Mori, Masaki Shiota, et al.
Scientific Reports|May 20, 2022
Cancer genomic profiling identified dihydropyrimidine dehydrogenase deficiency in bladder cancer promotes sensitivity to gemcitabineShigehiro Tsukahara, Masaki Shiota, Dai Takamatsu, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|February 2, 2024
Real-world sequential treatment patterns and clinical outcomes among patients with advanced urothelial carcinoma in JapanYuki Kita, Hikari Otsuka, Katsuhiro Ito, et al.
Pageof 4